Kiyoko Kawamura

1.6k total citations
46 papers, 1.3k citations indexed

About

Kiyoko Kawamura is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Kiyoko Kawamura has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 18 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Kiyoko Kawamura's work include Immune Cell Function and Interaction (13 papers), Virus-based gene therapy research (12 papers) and T-cell and B-cell Immunology (11 papers). Kiyoko Kawamura is often cited by papers focused on Immune Cell Function and Interaction (13 papers), Virus-based gene therapy research (12 papers) and T-cell and B-cell Immunology (11 papers). Kiyoko Kawamura collaborates with scholars based in Japan, China and Netherlands. Kiyoko Kawamura's co-authors include Masatoshi Tagawa, Osamu Shimozato, Shigeru Sakiyama, Masako Chiyo, Jiyang O‐Wang, Ling Yu, Quanhai Li, Takeshi Tokuhisa, Hiromitsu Saisho and Shin‐ichi Ugai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Kiyoko Kawamura

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiyoko Kawamura Japan 22 672 547 522 244 169 46 1.3k
Masahiko Ishihara Japan 10 682 1.0× 575 1.1× 767 1.5× 116 0.5× 286 1.7× 24 1.4k
Lucy T.C. Peltenburg Netherlands 19 435 0.6× 755 1.4× 484 0.9× 152 0.6× 116 0.7× 25 1.3k
Alexei F. Kirkin Denmark 20 655 1.0× 1.0k 1.9× 730 1.4× 98 0.4× 185 1.1× 43 1.7k
Juanita Campos-Torres United States 9 643 1.0× 627 1.1× 427 0.8× 106 0.4× 171 1.0× 11 1.4k
Tadanori Yamochi Japan 24 669 1.0× 1.1k 2.0× 617 1.2× 144 0.6× 391 2.3× 39 2.2k
Guang Huan Tu United States 9 520 0.8× 541 1.0× 599 1.1× 278 1.1× 63 0.4× 11 1.2k
J Tschopp Switzerland 9 937 1.4× 866 1.6× 438 0.8× 102 0.4× 216 1.3× 10 1.6k
Maren Kaufmann Germany 23 544 0.8× 928 1.7× 453 0.9× 140 0.6× 234 1.4× 63 1.7k
Karla A. Henning United States 12 704 1.0× 1.0k 1.8× 826 1.6× 229 0.9× 137 0.8× 23 1.9k
Alexey M. Chumakov United States 18 446 0.7× 727 1.3× 348 0.7× 165 0.7× 203 1.2× 32 1.3k

Countries citing papers authored by Kiyoko Kawamura

Since Specialization
Citations

This map shows the geographic impact of Kiyoko Kawamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyoko Kawamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyoko Kawamura more than expected).

Fields of papers citing papers by Kiyoko Kawamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyoko Kawamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyoko Kawamura. The network helps show where Kiyoko Kawamura may publish in the future.

Co-authorship network of co-authors of Kiyoko Kawamura

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyoko Kawamura. A scholar is included among the top collaborators of Kiyoko Kawamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyoko Kawamura. Kiyoko Kawamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Okamoto, Shinya, Yuanyuan Jiang, Kiyoko Kawamura, et al.. (2013). Zoledronic Acid Produces Combinatory Anti-Tumor Effects with Cisplatin on Mesothelioma by Increasing p53 Expression Levels. PLoS ONE. 8(3). e60297–e60297. 8 indexed citations
5.
Shimozato, Osamu, Ling Yu, Akihiko Wada, et al.. (2012). Expression of a murine homolog of apoptosis-inducing human IL-24/MDA-7 in murine tumors fails to induce apoptosis or produce anti-tumor effects. Cellular Immunology. 275(1-2). 90–97. 3 indexed citations
6.
Li, Quanhai, Kiyoko Kawamura, Guangyu Ma, et al.. (2009). Interferon-λ induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents. European Journal of Cancer. 46(1). 180–190. 72 indexed citations
7.
Ouchida, Rika, Akiko Ukai, Hiromi Mori, et al.. (2008). Genetic analysis reveals an intrinsic property of the germinal center B cells to generate A:T mutations. DNA repair. 7(8). 1392–1398. 10 indexed citations
8.
Ouchida, Rika, Sho Yamasaki, Masaki Hikida, et al.. (2008). A Lysosomal Protein Negatively Regulates Surface T Cell Antigen Receptor Expression by Promoting CD3ζ-Chain Degradation. Immunity. 29(1). 33–43. 61 indexed citations
9.
Masuda, Keiji, Rika Ouchida, Arata Takeuchi, et al.. (2005). DNA polymerase θ contributes to the generation of C/G mutations during somatic hypermutation of Ig genes. Proceedings of the National Academy of Sciences. 102(39). 13986–13991. 94 indexed citations
10.
Chiyo, Masako, Osamu Shimozato, Ling Yu, et al.. (2005). Expression of IL‐27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. International Journal of Cancer. 115(3). 437–442. 106 indexed citations
11.
Wada, Akihiko, Kiyoko Kawamura, Akemi Sakamoto, et al.. (2004). Impaired lymphocyte development and function in Clast5/Stra13/DEC1‐transgenic mice. European Journal of Immunology. 34(5). 1322–1332. 29 indexed citations
12.
Wang, Yanqing, Kiyoko Kawamura, Ling Yu, et al.. (2004). Elevated expression of DNA polymerase κ in human lung cancer is associated with p53 inactivation: Negative regulation of POLK promoter activity by p53. International Journal of Oncology. 25(1). 161–5. 31 indexed citations
13.
Wang, Yanqing, Shin‐ichi Ugai, Osamu Shimozato, et al.. (2003). Induction of systemic immunity by expression of interleukin‐23 in murine colon carcinoma cells. International Journal of Cancer. 105(6). 820–824. 49 indexed citations
14.
O‐Wang, Jiyang, Rumana Bahar, Kiyoko Kawamura, et al.. (2003). Stage-specific expression of Clast6/E3/LAPTM5 during B cell differentiation: elevated expression in human B lymphomas. International Journal of Oncology. 22(2). 301–4. 24 indexed citations
15.
Ugai, Shin‐ichi, Osamu Shimozato, Ling Yu, et al.. (2003). Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects. Cancer Gene Therapy. 10(10). 771–778. 61 indexed citations
16.
Bahar, Rumana, Yanqing Wang, Kiyoko Kawamura, et al.. (2002). Clast5/Stra13 Is a Negative Regulator of B Lymphocyte Activation. Biochemical and Biophysical Research Communications. 292(1). 121–127. 32 indexed citations
17.
Namba, Hiroki, Yasuo Iwadate, Kiyoko Kawamura, Shigeru Sakiyama, & Masatoshi Tagawa. (2001). Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells. Cancer Gene Therapy. 8(6). 414–420. 34 indexed citations
19.
Iwadate, Yasuo, Masatoshi Tagawa, Hiroki Namba, et al.. (2000). Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors. Cancer Gene Therapy. 7(9). 1263–1269. 6 indexed citations
20.
Kawamura, Kiyoko, et al.. (1990). Chromosome and gene rearrangements in immortalized human lymphocytes infected with human T-lymphotropic virus type I.. PubMed. 50(17 Suppl). 5697S–5702S. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026